EDUCATIONAL OBJECTIVES

• Discuss treatment options available for high risk MDS patients
• Examine new immune based therapies, including CAR T-cell therapy, in the treatment of multiple myeloma
• Describe therapeutic and molecular strategies for managing patients with Non-Hodgkin's lymphoma
• Examine the role of molecular testing for the management of AML
• Recognize some of the newer issues affecting the care of Hematology patients

TARGETED AUDIENCE

This conference is designed specifically for hematologists, medical oncologists, pharmacists, pharmacy techs, fellows, advanced practice professionals, oncology nurses and other healthcare professionals who are interested in this field.

ACCREDITATION

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of USF Health, Moffitt Cancer Center, the Leukemia and Lymphoma Society and the Florida  Society of Clinical Oncology.  USF Health is accredited by the ACCME to provide continuing medical education for physicians.

USF Health designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.